BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.87B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.2B |
| 3 |
Amazon
AMZN
|
+$1.9B |
| 4 |
NVIDIA
NVDA
|
+$1.86B |
| 5 |
Costco
COST
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.53B |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$1.81B |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$732M |
| 4 |
Super Micro Computer
SMCI
|
+$728M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOGC
3326
DELISTED
ContextLogic
LOGC
| $9.21M | ﹤0.01% |
1,618,627
+10,272
| +0.6% | +$56.6K |
|
3327
Atomera
ATOM
$212M
| $9.19M | ﹤0.01% |
1,492,512
-42,326
| -3% | -$290K |
|
3328
Design Therapeutics
DSGN
$901M
| $9.16M | ﹤0.01% |
2,274,191
-106,051
| -4% | -$283K |
|
3329
NACCO Industries
NC
$316M
| $9.1M | ﹤0.01% |
301,470
-8,642
| -3% | -$293K |
|
3330
Pulse Biosciences
PLSE
$3.2B
| $9.1M | ﹤0.01% |
1,044,808
-26,928
| -3% | -$248K |
|
|
SMLR
3331
DELISTED
Semler Scientific
SMLR
| $9.06M | ﹤0.01% |
310,252
-11,551
| -4% | -$482K |
|
3332
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$114M
| $9.06M | ﹤0.01% |
334,902
+16,929
| +5% | +$473K |
|
|
SCPH
3333
DELISTED
scPharmaceuticals
SCPH
| $9.04M | ﹤0.01% |
1,801,610
-61,829
| -3% | -$346K |
|
|
NYXH
3334
Nyxoah
NYXH
$158M
| $9.04M | ﹤0.01% |
670,267
+16,283
| +2% | +$186K |
|
|
HUYA
3335
Huya Inc
HUYA
$538M
| $9.02M | ﹤0.01% |
1,981,410
+6,943
| +0.4% | +$25.1K |
|
3336
C&F Financial
CFFI
$288M
| $8.97M | ﹤0.01% |
182,995
-8,181
| -4% | -$450K |
|
3337
Milestone Pharmaceuticals
MIST
$133M
| $8.9M | ﹤0.01% |
4,971,344
+1,700,595
| +52% | +$2.76M |
|
|
SGMO
3338
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $8.9M | ﹤0.01% |
13,277,637
-818,228
| -6% | -$593K |
|
3339
Aveanna Healthcare
AVAH
$2.46B
| $8.89M | ﹤0.01% |
3,571,621
-103,612
| -3% | -$250K |
|
3340
Chemung Financial Corp
CHMG
$403M
| $8.89M | ﹤0.01% |
209,336
-8,719
| -4% | -$391K |
|
|
NREF
3341
NexPoint Real Estate Finance
NREF
$318M
| $8.89M | ﹤0.01% |
619,261
-19
| -0% | -$278 |
|
3342
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$378M
| $8.89M | ﹤0.01% |
151,082
+13,494
| +10% | +$779K |
|
3343
Douglas Elliman
DOUG
$183M
| $8.89M | ﹤0.01% |
5,625,676
-110,657
| -2% | -$227K |
|
|
QIPT
3344
DELISTED
Quipt Home Medical
QIPT
| $8.88M | ﹤0.01% |
2,032,136
-78,336
| -4% | -$354K |
|
|
BRFS
3345
DELISTED
BRF SA
BRFS
| $8.86M | ﹤0.01% |
2,718,905
+799,814
| +42% | +$2.35M |
|
3346
Foghorn Therapeutics
FHTX
$385M
| $8.83M | ﹤0.01% |
1,315,371
+9,503
| +0.7% | +$52.8K |
|
3347
HF Foods Group
HFFG
$97.6M
| $8.77M | ﹤0.01% |
2,506,225
-93,662
| -4% | -$410K |
|
3348
Corbus Pharmaceuticals
CRBP
$195M
| $8.67M | ﹤0.01% |
220,862
+139,797
| +172% | +$3.45M |
|
|
TGAN
3349
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $8.64M | ﹤0.01% |
1,760,478
+87,520
| +5% | +$415K |
|
3350
Rentokil
RTO
$12.1B
| $8.64M | ﹤0.01% |
286,625
+69,485
| +32% | +$1.93M |
|
Similar funds
BlackRock's Q1 2024 Portfolio in Review
As of Q1 2024, BlackRock held 5,499 positions worth $4.3T, up 9.5% from $3.92T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BlackRock's Q1 2024 filing shows 129 new, 1,833 increased, 2,801 reduced and 210 closed positions. Its largest new stake was Arcadium Lithium plc: 122,471,992 shares worth $528M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.53B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2024 buy was Arcadium Lithium plc: 122,471,992 shares worth $528M.
- BlackRock added most to Microsoft in Q1 2024, an estimated $2.87B increase.
- BlackRock's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.53B.
- BlackRock fully exited Splunk Inc in Q1 2024, selling an estimated $1.81B.
- BlackRock's ten largest holdings make up 24% of its $4.3T portfolio in Q1 2024.
- BlackRock opened 129 new positions and closed 210 in Q1 2024.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $4.3T.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.